Peripheral Arterial Disease Drugs Market
1 Introduction to Research & Analysis Reports
1.1 Peripheral Arterial Disease (PAD) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peripheral Arterial Disease (PAD) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peripheral Arterial Disease (PAD) Drugs Overall Market Size
2.1 Global Peripheral Arterial Disease (PAD) Drugs Market Size: 2021 VS 2028
2.2 Global Peripheral Arterial Disease (PAD) Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peripheral Arterial Disease (PAD) Drugs Players in Global Market
3.2 Top Global Peripheral Arterial Disease (PAD) Drugs Companies Ranked by Revenue
3.3 Global Peripheral Arterial Disease (PAD) Drugs Revenue by Companies
3.4 Top 3 and Top 5 Peripheral Arterial Disease (PAD) Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Peripheral Arterial Disease (PAD) Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peripheral Arterial Disease (PAD) Drugs Players in Global Market
3.6.1 List of Global Tier 1 Peripheral Arterial Disease (PAD) Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Peripheral Arterial Disease (PAD) Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Peripheral Arterial Disease (PAD) Drugs Market Size Markets, 2021 & 2028
4.1.2 Clopidogrel (Plavix)
4.1.3 Prasugrel (Effient)
4.1.4 Ticagrelor (Brilinta)
4.1.5 Vorapaxar (Zontivity)
4.1.6 Others
4.2 By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue & Forecasts
4.2.1 By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2017-2022
4.2.2 By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2023-2028
4.2.3 By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peripheral Arterial Disease (PAD) Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue & Forecasts
5.2.1 By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2017-2022
5.2.2 By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2023-2028
5.2.3 By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Peripheral Arterial Disease (PAD) Drugs Market Size, 2021 & 2028
6.2 By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue & Forecasts
6.2.1 By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2017-2022
6.2.2 By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2023-2028
6.2.3 By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Peripheral Arterial Disease (PAD) Drugs Revenue, 2017-2028
6.3.2 US Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.3.3 Canada Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.3.4 Mexico Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Peripheral Arterial Disease (PAD) Drugs Revenue, 2017-2028
6.4.2 Germany Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.4.3 France Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.4.4 U.K. Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.4.5 Italy Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.4.6 Russia Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.4.8 Benelux Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Peripheral Arterial Disease (PAD) Drugs Revenue, 2017-2028
6.5.2 China Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.5.3 Japan Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.5.4 South Korea Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.5.6 India Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Peripheral Arterial Disease (PAD) Drugs Revenue, 2017-2028
6.6.2 Brazil Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.6.3 Argentina Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue, 2017-2028
6.7.2 Turkey Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.7.3 Israel Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
6.7.5 UAE Peripheral Arterial Disease (PAD) Drugs Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca (UK)
7.1.1 AstraZeneca (UK) Corporate Summary
7.1.2 AstraZeneca (UK) Business Overview
7.1.3 AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.1.4 AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca (UK) Key News
7.2 Bayer HealthCare Pharmaceuticals (Germany)
7.2.1 Bayer HealthCare Pharmaceuticals (Germany) Corporate Summary
7.2.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
7.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.2.4 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2017-2022)
7.2.5 Bayer HealthCare Pharmaceuticals (Germany) Key News
7.3 Bristol-Myers Squibb Company (US)
7.3.1 Bristol-Myers Squibb Company (US) Corporate Summary
7.3.2 Bristol-Myers Squibb Company (US) Business Overview
7.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.3.4 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2017-2022)
7.3.5 Bristol-Myers Squibb Company (US) Key News
7.4 Merck & Co (US)
7.4.1 Merck & Co (US) Corporate Summary
7.4.2 Merck & Co (US) Business Overview
7.4.3 Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.4.4 Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2017-2022)
7.4.5 Merck & Co (US) Key News
7.5 Proteon Therapeutics (US)
7.5.1 Proteon Therapeutics (US) Corporate Summary
7.5.2 Proteon Therapeutics (US) Business Overview
7.5.3 Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.5.4 Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2017-2022)
7.5.5 Proteon Therapeutics (US) Key News
7.6 Sanofi (France)
7.6.1 Sanofi (France) Corporate Summary
7.6.2 Sanofi (France) Business Overview
7.6.3 Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.6.4 Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2017-2022)
7.6.5 Sanofi (France) Key News
7.7 Symic Bio (US)
7.7.1 Symic Bio (US) Corporate Summary
7.7.2 Symic Bio (US) Business Overview
7.7.3 Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.7.4 Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2017-2022)
7.7.5 Symic Bio (US) Key News
7.8 TheraVasc (US)
7.8.1 TheraVasc (US) Corporate Summary
7.8.2 TheraVasc (US) Business Overview
7.8.3 TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.8.4 TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2017-2022)
7.8.5 TheraVasc (US) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Peripheral Arterial Disease (PAD) Drugs Market Opportunities & Trends in Global Market
Table 2. Peripheral Arterial Disease (PAD) Drugs Market Drivers in Global Market
Table 3. Peripheral Arterial Disease (PAD) Drugs Market Restraints in Global Market
Table 4. Key Players of Peripheral Arterial Disease (PAD) Drugs in Global Market
Table 5. Top Peripheral Arterial Disease (PAD) Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Peripheral Arterial Disease (PAD) Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Peripheral Arterial Disease (PAD) Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Peripheral Arterial Disease (PAD) Drugs Product Type
Table 9. List of Global Tier 1 Peripheral Arterial Disease (PAD) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peripheral Arterial Disease (PAD) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Peripheral Arterial Disease (PAD) Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Peripheral Arterial Disease (PAD) Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Peripheral Arterial Disease (PAD) Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Peripheral Arterial Disease (PAD) Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca (UK) Corporate Summary
Table 31. AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 32. AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Bayer HealthCare Pharmaceuticals (Germany) Corporate Summary
Table 34. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 35. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Company (US) Corporate Summary
Table 37. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 38. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Merck & Co (US) Corporate Summary
Table 40. Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 41. Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Proteon Therapeutics (US) Corporate Summary
Table 43. Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 44. Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi (France) Corporate Summary
Table 46. Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 47. Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Symic Bio (US) Corporate Summary
Table 49. Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 50. Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn), (2017-2022)
Table 51. TheraVasc (US) Corporate Summary
Table 52. TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 53. TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Peripheral Arterial Disease (PAD) Drugs Segment by Type in 2021
Figure 2. Peripheral Arterial Disease (PAD) Drugs Segment by Application in 2021
Figure 3. Global Peripheral Arterial Disease (PAD) Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Peripheral Arterial Disease (PAD) Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peripheral Arterial Disease (PAD) Drugs Revenue in 2021
Figure 8. By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2017-2028
Figure 12. US Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2017-2028
Figure 24. China Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
